These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25574531)

  • 1. Cancer cell metabolism as new targets for novel designed therapies.
    Marín de Mas I; Aguilar E; Jayaraman A; Polat IH; Martín-Bernabé A; Bharat R; Foguet C; Milà E; Papp B; Centelles JJ; Cascante M
    Future Med Chem; 2014; 6(16):1791-810. PubMed ID: 25574531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pursuit of Therapeutic Biomarkers with High-Throughput Cancer Cell Drug Screens.
    Williams SP; McDermott U
    Cell Chem Biol; 2017 Sep; 24(9):1066-1074. PubMed ID: 28736238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical development of cancer therapeutics that target metabolism.
    Clem BF; O'Neal J; Klarer AC; Telang S; Chesney J
    QJM; 2016 Jun; 109(6):367-72. PubMed ID: 26428335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
    Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
    Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-scale modeling of human metabolism - a systems biology approach.
    Mardinoglu A; Gatto F; Nielsen J
    Biotechnol J; 2013 Sep; 8(9):985-96. PubMed ID: 23613448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-carbon metabolism for cancer diagnostic and therapeutic approaches.
    Asai A; Konno M; Koseki J; Taniguchi M; Vecchione A; Ishii H
    Cancer Lett; 2020 Feb; 470():141-148. PubMed ID: 31759958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy.
    Shi Y; Liu S; Ahmad S; Gao Q
    Curr Top Med Chem; 2018; 18(6):454-466. PubMed ID: 29788889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Cancer Metabolism by Phytochemicals - A Brief Overview.
    Muntean DM; Sturza A; Pavel IZ; Duicu OM
    Anticancer Agents Med Chem; 2018; 18(5):684-692. PubMed ID: 29141558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
    Jimenez CR; Verheul HM
    Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 3D pharmacophore mapping based virtual screening for identification of novel anticancer agents: an overview.
    Halder AK; Saha A; Jha T
    Curr Top Med Chem; 2013; 13(9):1098-126. PubMed ID: 23651485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in cancer drug discovery - a British association for cancer research meeting.
    Westwell AD
    IDrugs; 2008 Nov; 11(11):783-6. PubMed ID: 18988118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies on the development of small molecule anticancer drugs for targeted therapy.
    Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
    Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.